Abstract

Tumor megaprostheses are modular systems commonly used for joint reconstructions following bone resection. In the last two decades, indications on the use of modular prostheses have progressively increased even in non-cancer patients, mainly as a review of implants, in particularly favorable conditions for hip and knee and with severe bone loss. Aim of this study is to define the current indications in the use of megaprostheses as revision implant in non-cancer patients, based on the experience of a reference cancer center and the data reported in the literature.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call